| Literature DB >> 27660671 |
Tomohide Hori1, Yasuhiro Ogura1, Yasuharu Onishi1, Hideya Kamei1, Nobuhiko Kurata1, Motoshi Kainuma1, Hideo Takahashi1, Shogo Suzuki1, Takashi Ichikawa1, Shoko Mizuno1, Tadashi Aoyama1, Yuki Ishida1, Takahiro Hirai1, Tomoko Hayashi1, Kazuko Hasegawa1, Hiromu Takeichi1, Atsunobu Ota1, Yasuhiro Kodera1, Hiroyuki Sugimoto1, Taku Iida1, Shintaro Yagi1, Kentaro Taniguchi1, Shinji Uemoto1.
Abstract
Advanced liver cirrhosis is usually accompanied by portal hypertension. Long-term portal hypertension results in various vascular alterations. The systemic hemodynamic state in patients with cirrhosis is termed a hyperdynamic state. This peculiar hemodynamic state is characterized by an expanded blood volume, high cardiac output, and low total peripheral resistance. Vascular alterations do not disappear even long after liver transplantation (LT), and recipients with cirrhosis exhibit a persistent systemic hyperdynamic state even after LT. Stability of optimal systemic hemodynamics is indispensable for adequate portal venous flow (PVF) and successful LT, and reliable parameters for optimal systemic hemodynamics and adequate PVF are required. Even a subtle disorder in systemic hemodynamics is precisely indicated by the balance between cardiac output and blood volume. The indocyanine green (ICG) kinetics reflect the patient's functional hepatocytes and effective PVF, and PVF is a major determinant of the ICG elimination constant (kICG) in the well-preserved allograft. The kICG value is useful to set the optimal PVF during living-donor LT and to evaluate adequate PVF after LT. Perioperative management has a large influence on the postoperative course and outcome; therefore, key points and unexpected pitfalls for intensive management are herein summarized. Transplant physicians should fully understand the peculiar systemic hemodynamic behavior in LT recipients with cirrhosis and recognize the critical importance of PVF after LT.Entities:
Keywords: Hyperdynamic; Indocyanine green; Liver cirrhosis; Liver transplantation; Portal hypertension
Year: 2016 PMID: 27660671 PMCID: PMC5026996 DOI: 10.4254/wjh.v8.i25.1047
Source DB: PubMed Journal: World J Hepatol